公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2019 | Nanomedicine-based Curcumin Approach Improved ROS Damage in Best Dystrophy-specific Induced Pluripotent Stem Cells | Lin T.-C.; Lin Y.-Y.; Hsu C.-C.; Yang Y.-P.; CHANG-HAO YANG ; Hwang D.-K.; Wang C.-Y.; Liu Y.-Y.; Lo W.-L.; Chiou S.-H.; Peng C.-H.; Chen S.-J.; Chang Y.-L. | Cell Transplantation | 14 | 12 | |
2006 | A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma | Tsai M.-F.; Wang C.-C.; Chang G.-C.; Chen C.-Y.; Chen H.-Y.; Cheng C.-L.; Yang Y.-P.; Wu C.-Y.; Shih F.-Y.; Liu C.-C.; Lin H.-P.; Jou Y.-S.; Lin S.-C.; CHUNG-WU LIN ; WEI J. CHEN ; Chan W.-K.; Chen J.J.W.; PAN-CHYR YANG | Journal of the National Cancer Institute | 102 | 98 | |
2006 | Proton exchange membrane fuel cell system identification and control - Part I: System dynamics, modeling and identification | Yang Y.-P.; Wang F.-C. ; Chang H.-P.; Ma Y.-W.; Huang C.-W.; Weng B.-J. | 4th International ASME Conference on Fuel Cell Science, Engineering and Technology | 0 | ||
2018 | Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan | LI-KAI TSAI ; Lin H.-J.; Chua S.-K.; Liao P.-C.; Yang Y.-P.; Chou P.-C.; Lee C.-W.; Lin M.-J.; Chen H.-M.; Yeh J.-T.; Li Y.-H. | Journal of Stroke and Cerebrovascular Diseases | 13 | 14 | |
2018 | Reducing the time needed to administer a sustained attention test in patients with stroke | Lin G.-H.; Yang Y.-P.; Yang J.-F.; Chen T.-T.; CHING-LIN HSIEH | PLoS ONE | 2 | 2 | |
2022 | Retinal Circular RNA hsa_circ_0087207 Expression Promotes Apoptotic Cell Death in Induced Pluripotent Stem Cell-Derived Leber’s Hereditary Optic Neuropathy-like Models | Yang Y.-P.; Chang Y.-L.; Lai Y.-H.; Tsai P.-H.; Hsiao Y.-J.; Nguyen L.H.; Lim X.-Z.; Weng C.-C.; Ko Y.-L.; CHANG-HAO YANG ; Hwang D.-K.; Chen S.-J.; Chiou S.-H.; Chiou G.-Y.; Wang A.-G.; Chien Y. | Biomedicines | 1 | 1 | |
2013 | Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer | Pao J.-B.; Yang Y.-P.; Huang C.-N.; Huang S.-P.; Hour T.-C.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; CHAO-YUAN HUANG ; Bao B.-Y. | World Journal of Urology | 11 | 10 |